Dykema (Cannabis Law Blog)

APRIL 20, 2023

The medicinal use of cannabis in the Texas Compassionate Use Act (the “Act”, 2015), provides for the medical sale and use of cannabis for individuals with specific defined illnesses. Recreational use of cannabis in Texas remains restrictive, with law enforcement being inconsistent even between Texas cities. Specifically, H.B.

Law 74

Law Chronic Pain Conditions Medicine 74

Miss Marijuana

MAY 9, 2021

According to a study published in September 2015 by Esther M. CBD as a treatment for Autism Spectrum Disorder. There are also studies with promising results in palliative treatments for cancer patients and people who have insomnia. Blessing et al., In 2019, Fleury-Texeira et al. In 2019, Fleury-Texeira et al.

CBD 98

CBD Cannabinoids Sleep Treatment 98

Canna Care Docs

DECEMBER 16, 2020

It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. Enough is enough. Multiple sclerosis. Psychiatric disorders like depression, anxiety, and PTSD.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Veriheal

SEPTEMBER 15, 2023

In 2015, Georgia passed HB 1, also known as the Haleigh’s Hope Act, allowing medical cannabis oil for medical use. The medical conditions that qualify for this program typically include severe and debilitating conditions like epilepsy, cancer, multiple sclerosis, and Parkinson’s disease, among others.

Programs 62

Programs Legalization Oil Conditions 62

Alchimia

JUNE 20, 2016

A study published in February 2015 in the Pharmacology & Pharmacy journal showed that a CBD-rich extract from cannabis plants is much more efficient than CBD used in its pure form , mainly due the presence of other cannabinoids, terpenes and other molecules that greatly increase the dosage/efficiency ratio of CBD.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Cannabis Law Report

JULY 30, 2021

Fifty-nine-year old Dragoljub Mrdjic has suffered from epilepsy for most of his life. Few medicines have helped him, but his condition drastically improved after he started treating himself with cannabis oil in 2001. “I I tried standard medicine, but there wasn’t much of a result.

Patients 105

Patients Oil Marijuana Medicine 105

The Joint Blog

MAY 28, 2019

Today cannabis doctors across these states and countries prescribe cannabis-based treatments to ease various ailments and discomfort associated with them. One such ailment that has been facing a tough front in terms of medication is Epilepsy. Cannabis, in fact, could be the miracle that Epilepsy patients have been hoping for.

Oil 42

Oil Epilepsy CBD Treatment 42

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Veriheal

NOVEMBER 20, 2020

In 2015, Representative David Simpson introduced a bill to legalize on religious grounds, stating, “I don’t believe that when God made marijuana, He made a mistake that the government needs to fix.”. This bill also allowed for previously convicted offenders to be resentenced under the terms of the new law.

Legalization 98

Legalization Epilepsy Cannabis Legislation 98

The Joint Blog

JANUARY 10, 2022

Hence, CBD is an enticing choice for those looking for pain relief and treatments that lack the mind-altering impact of cannabis or the additional adverse effects associated with some pharmaceutical medicines. Due to CBD’s relaxing effect, it may be helpful in the treatment of sleep disorders. PTSD affects about 6.1

CBD 41

CBD Sleep Treatment Epilepsy 41

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition.

Sativa 59

Sativa Medicine Legalization Epilepsy 59

CannaTech

JANUARY 16, 2019

Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

MARCH 29, 2019

However, the Lone Star State could make significant progress toward expanding the Compassionate Use Program and putting medical treatment choices for certain medical conditions into the hands of medical providers and patients rather than politicians. Currently, only epilepsy patients may use the drug produced at three state facilities.

Epilepsy 45

Epilepsy Law Chronic Pain Programs 45

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Kind Meds (Cannabis Education Blog)

JANUARY 7, 2019

In addition, the cost of healthcare has made many older Americans forego a necessary trip to their doctor and, for some, deny themselves treatment for what ails them. The details are based on a study conducted in Israel from 2015 through October 2017. Alternative Treatments for Pain, Physical and Mental Illness. Alzheimer’s.

Marijuana 83

Marijuana Treatment Chronic Pain Strains 83

Cannabis Law Report

FEBRUARY 19, 2022

Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers. As of 2015, however, Tennessee authorizes the use of cannabidiol oil with less than 0.9% Medical cannabis is still illegal in Tennessee.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

Veriheal

MAY 31, 2022

But even with the TTOR’s focus on prevention, treatment, and recovery, illicit operations continue to wreak havoc. With its anti-inflammatory properties and ability to block pain signals in the brain , cannabis is becoming one of the most popular alternative treatments for chronic pain. Vital Changes to Texas’ Medical Cannabis Program.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

SEPTEMBER 6, 2019

A 2015 study published in Sage’s Journal of Psychopharmacology , for instance, found that low doses of THCV inhibited the intoxicating effects of THC. A 2015 study found that the effect of it on the CB1 receptors suggested a potential to treating obesity. milligrams, THCV inhibits appetite by antagonizing the CB1 receptors.

Cannabinoids 49

Cannabinoids THC Strains CBD 49

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., But things have changed after FDA eased out regulations in 2015 to carry out CBD trials. But what makes CBD different from other cannabinoids is its therapeutic properties.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

Canna Care Docs

SEPTEMBER 18, 2020

Governor Terry McAuliffe signed House Bill 1445 and Senate Bill 1235 in March 2015. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. You may check to see if Virginia has been added to the states DC includes at their website: [link]. History of Medical Marijuana in Virginia.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

MassRoots

MAY 12, 2020

It all began in 2015 when Georgia lawmakers approved legislation to allow registered medical marijuana patients in the state to possess and use up to 20 fluid ounces of low-THC cannabis oil. A Brief History. For many patients, low-THC oil and CBD isolates simply are not enough to treat debilitating symptoms. .

Oil 53

Oil Programs Access Patients 53

Cannabis Law Report

JULY 28, 2021

To date, 81 warning letters have been sent since 2015. Despite a thriving market, CBD is only approved for use by the FDA in very few scenarios, including for the treatment of epilepsy through a drug called Epidiolex. Skin health or acne treatment. Consumers deserve and need to feel safe when buying CBD products.

CBD 98

CBD Food Treatment Conditions 98

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. Results of the treatment.

Oil 40

Oil Treatment Patients THC 40

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: SIPSE.COM ).

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

DECEMBER 9, 2019

Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. That said, research conducted to date has been promising, with CBD demonstrating the potential for aiding with a wide range of health conditions and resulting symptoms. Depression. Inflammation.

Pets 59

Pets CBD Research and Development Epilepsy 59

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

SEPTEMBER 23, 2019

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MARCH 12, 2021

And so, they’re trying to standardize, trying to make sure that doctors are are generally coming at problems from a similar perspective, and especially they’re coming at treatments from a similar perspective. MSO: Yeah, it’s very different. But there’s a lot of space in between there.

Legalization 130

Legalization Patients Education Dispensary 130

Cannabis Law Report

SEPTEMBER 6, 2021

The global medical cannabis market exhibited strong growth during 2015-2020. Cannabis is safer and has less severe side effects in comparison to other treatment options. It also finds usage along with other treatments either to enhance their efficacy or to combat adverse side effects. during 2021-2026. Companies Mentioned.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. million Americans annually. Terpenes.

THC 64

THC CBD Cannabinoids Research and Development 64

CannaMD

AUGUST 19, 2020

Unlike THC, CBD has a high margin of safety and is well tolerated pharmacologically even after treatments of up to 1500 mg/day for two weeks in both animals and humans, which suggests its feasibility to reduce SARS-CoV2 induced lung inflammation/pathology and disease severity. .” sativa is a novel and crucial finding. Get Started.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

JANUARY 26, 2022

MDMA as an adjunct to therapy for PTSD is the forty-first treatment to receive the Innovation Passport since its inception in January 2021. The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Cannabis Law Report

OCTOBER 26, 2019

doctors) for patients who are ‘seriously ill with a condition from which death is reasonably likely to occur within a matter of months, or from which premature death is reasonably likely to occur in the absence of early treatment’ Category B is an application pathway that can be accessed by health practitioners (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Green Relief

MAY 12, 2018

It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. According to a 2015 study in Neurotherapeutics , “Upregulation of CB2 with no changes in CB1 have been found in TBI.”. million Americans annually. Terpenes.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

OCTOBER 20, 2019

sat on the Denver County Court bench 2000-2015. It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Kleignen, 2015. Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.” Kleignen, 2015. Author Biography. Judge Mary A.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45